NCT05046457View on ClinicalTrials.gov

Beta-cryptoxanthin Supplement: Absorption and Function

NACompletedINTERVENTIONAL
Enrollment

90

Participants

Timeline

Start Date

September 7, 2021

Primary Completion Date

March 31, 2022

Study Completion Date

March 31, 2022

Conditions
Beta-cryptoxanthin Supplementation
Interventions
DIETARY_SUPPLEMENT

Beta-cryptoxanthin (BCX)

Subjects will be randomised into one of the three study treatment arms.

Trial Locations (1)

Unknown

Singapore Institute for Clinical Sciences, Singapore

All Listed Sponsors
collaborator

DSM Nutritional Products, Inc.

INDUSTRY

lead

Institute for Human Development and Potential (IHDP), Singapore

OTHER

NCT05046457 - Beta-cryptoxanthin Supplement: Absorption and Function | Biotech Hunter | Biotech Hunter